Lin Mu, M.D., MBA

Lin is a Vice President on the Frazier Life Sciences team and focuses on identifying and evaluating new investment opportunities.

Lin joined Frazier Life Sciences in 2024, where he focuses on evaluating investment opportunities and creating new ventures in the life sciences.

Prior to joining Frazier, Lin was a management consultant with Boston Consulting Group’s health care practice, where he advised biopharmaceutical clients on development and commercialization strategies. Previously, Lin was a clinical researcher at Beth Israel Deaconess Medical Center, where he supported clinical trial operations across therapeutic areas. His work has been published in top medical journals including The Lancet and is widely cited in epidemiology and outcomes research.

Lin received his M.D. from Yale University, MBA from University of Cambridge, and B.S. in Biology and B.A. in Economics from Denison University.